The FDA issued an emergency use authorization allowing healthcare providers to administer less of the monkeypox vaccine amid an escalating outbreak in the U.S. that is outstripping supply.
In a press briefing at the White House, the FDA commissioner acknowledged the spread of monkeypox has outpaced vaccine supply and said the new dosing method — intradermally rather than subcutaneously — will multiply the total number of available doses by up to five.
References
Related Timelines
This topic is part of 2 timelines. Explore the complete timeline to see this item in a broader context.